Mycoplasma pneumoniae IgA Control Serum BC127A

$94.00

Summary

Virion/Serion Diagnostic Kit Control for research use (RUO)
Mycoplasma pneumoniae IgA Control Serum
Applications: ELISA
IgA control serum
Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
3 mL

SKU: BC127A Categories: control serum, Virion/Serion kits Tags: ELISA control serum, IgA, Mycoplasma pneumoniae

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Mycoplasma pneumoniae reactive IgA
species reactivity	Mycoplasma pneumoniae
applications	ELISA
assay type	Indirect & quantitative
available size	3 mL

Mycoplasma pneumoniae IgA Control Serum BC127A

kit
Research area Infectious Disease
Storage Store at 2-8°C.
Associated products Mycoplasma pneumoniae Antigen (BA127VS) Mycoplasma pneumoniae P1 Antigen (BA127VSP1) Mycoplasma pneumoniae IgA Control Serum (BC127A) Mycoplasma pneumoniae IgG Control Serum (BC127G) Mycoplasma pneumoniae IgM Control Serum (BC127M) Mycoplasma pneumoniae IgA ELISA Kit (ESR127A) Mycoplasma pneumoniae IgG ELISA Kit (ESR127G) Mycoplasma pneumoniae IgM ELISA Kit (ESR127M)

target relevance

human antibody anti-Mycoplasma pneumoniae

Mycoplasma pneumoniae

Description
Bacterium that causes atypical pneumonia and respiratory tract infections

Structure
Mycoplasma pneumoniae is a small, self-replicating bacterium belonging to the family Mycoplasmataceae. Unlike most bacteria, M. pneumoniae lacks a cell wall and is instead surrounded by a sterol-containing cell membrane, making it naturally resistant to beta-lactam antibiotics such as penicillins and cephalosporins. The organism is highly specialized for colonization of the human respiratory tract, where it attaches to ciliated epithelial cells using a specialized attachment organelle. Mycoplasma pneumoniae is one of the smallest free-living organisms capable of independent replication and possesses a highly reduced genome reflecting its dependence on host-derived nutrients. The bacterium is transmitted through respiratory droplets and is a common cause of community-acquired respiratory infections worldwide, particularly among school-aged children, adolescents, and young adults.

Diagnosis
The diagnosis of Mycoplasma pneumoniae infection is performed through molecular, serological, and microbiological methods. Polymerase chain reaction (PCR) assays are considered the most sensitive and specific diagnostic tools and allow rapid detection of M. pneumoniae DNA from respiratory specimens. Serological assays, including ELISA-based tests, are commonly used to detect Mycoplasma-specific IgM and IgG antibodies and may assist in the diagnosis of acute or recent infection. Culture of M. pneumoniae is possible using specialized media but is rarely performed in routine clinical practice due to slow growth and technical complexity. Chest radiography may reveal diffuse or patchy infiltrates that are often disproportionate to the severity of clinical symptoms. Laboratory confirmation is particularly useful because clinical findings frequently overlap with those of viral respiratory infections.

Symptoms
Mycoplasma pneumoniae infection typically develops following an incubation period of approximately one to four weeks. Common symptoms include persistent dry cough, sore throat, fever, headache, fatigue, and malaise. Respiratory illness often begins gradually and may progress from upper respiratory tract infection to atypical pneumonia characterized by prolonged cough and diffuse pulmonary involvement. Many patients remain ambulatory despite radiographic evidence of pneumonia, leading to the term 'walking pneumonia.' Extrapulmonary manifestations may occur and can include skin rashes, hemolytic anemia, myocarditis, pericarditis, hepatitis, arthritis, and neurological complications such as encephalitis or Guillain-Barré syndrome. Although most infections are self-limiting, severe disease may occur in immunocompromised individuals and patients with underlying respiratory conditions.

Data

FAQ & Publications

Frequently Asked Questions

What is the intended application for the Mycoplasma pneumoniae IgA Control Serum BC127A?

The Mycoplasma pneumoniae IgA Control Serum BC127A is intended for use in ELISA applications as an IgA control serum, specifically compatible with SERION ELISA classic and SERION ELISA antigen assays.

How should the Mycoplasma pneumoniae IgA Control Serum BC127A be stored to maintain its stability?

This control serum should be stored at 2-8°C to ensure its stability and proper performance for research use.

Is the Mycoplasma pneumoniae IgA Control Serum BC127A species-specific, and if so, which species does it target?

Yes, the serum is species-reactive with Mycoplasma pneumoniae, targeting IgA antibodies reactive to this human pathogen.

What is the format and volume of the Mycoplasma pneumoniae IgA Control Serum BC127A provided?

The product is supplied as a ready-to-use, pre-diluted serum in a 3 mL volume suitable for ELISA assays.

Can the Mycoplasma pneumoniae IgA Control Serum BC127A be used for quantitative analysis, and what assay type does it support?

Yes, it supports indirect and quantitative ELISA assays, allowing for measurement of Mycoplasma pneumoniae reactive IgA levels.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC127A protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Mycoplasma pneumoniae IgA Control Serum BC127A

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Candida albicans IgA Control Serum BC117A

Yersinia IgA Control Serum BC138A

Campylobacter jejuni IgA Control Serum BC139A

Respiratory Syncytial Virus IgA Control Serum BC113A

Brucella IgA Control Serum BC116A

Mycoplasma pneumoniae IgG Control Serum BC127G

Bordetella pertussis IgA Control Serum BC120A

Mycoplasma pneumoniae IgM Control Serum BC127M

Adenovirus IgA Control Serum BC128A

Helicobacter pylori IgA Control Serum BC118A

Enterovirus IgA Control Serum BC133A

Echovirus IgA Control Serum BC135A

Coxsackie IgA Virus Control Serum BC134A

Chlamydia trachomatis IgA Control Serum BC1372A

Chlamydia pneumoniae IgA Control Serum BC1371A